There is no single gold-standard test to diagnose Cushing's syndrome. Current standard practice relies on the low-dose dexamethasone suppression test (LDDST). It has been proposed, however ...

Suppression of the HPA axis affects a patient's ability to respond to an acute stressful event and chronically causes the axis to atrophy. Typical doses of dexamethasone used in the brain tumor ...

Toxic epidermal necrolysis possible with thalidomide. Concomitant indomethacin: may get false-negative on dexamethasone suppression test. May suppress reactions to skin tests. HPA axis suppression ...

Toxic epidermal necrolysis possible with thalidomide. Concomitant indomethacin: may get false-negative on dexamethasone suppression test. May suppress reactions to skin tests. HPA axis suppression ...